Polyclonal Rabbit anti‑Coronavirus SARS‑CoV Spike Glycoprotein Antibody (aa288‑303, WB) LS‑C19351
Polyclonal Rabbit anti‑Coronavirus SARS‑CoV Spike Glycoprotein Antibody (aa288‑303, WB) LS‑C19351
Note: This antibody replaces LS-C38998
Antibody:
SARS-CoV Spike Glycoprotein Rabbit anti-Coronavirus SARS-CoV Polyclonal (aa288-303) Antibody
Reactivity:
Coronavirus SARS-CoV
Format:
Unconjugated, Unmodified
Overview
Antibody:
SARS-CoV Spike Glycoprotein Rabbit anti-Coronavirus SARS-CoV Polyclonal (aa288-303) Antibody
Reactivity:
Coronavirus SARS-CoV
Format:
Unconjugated, Unmodified
Specifications
Description
SARS-CoV Spike Glycoprotein antibody LS-C19351 is an unconjugated rabbit polyclonal antibody to coronavirus sars-cov Spike Glycoprotein (aa288-303). Validated for ELISA and WB.
Target
Coronavirus SARS-CoV SARS-CoV Spike Glycoprotein
Synonyms
E2 | S E2 glycoprotein | E2 glycoprotein precursor | S
Reactivity
Coronavirus SARS-CoV
(tested or 100% immunogen sequence identity)
Conjugations
Unconjugated
Purification
Protein G purified
Specificity
The was tested on a cell line transfected with a partial-length cDNA coding for the N-terminal portion of SARS Spike protein with a predicted molecular weight of 68 kD.
Applications
- Western blot (1 µg/ml)
- ELISA (1 µg/ml)
Presentation
PBS, 0.05% Sodium Azide, 0.2% Gelatin
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About SARS-CoV Spike Glycoprotein
Featured Products
Species:
Coronavirus SARS-CoV
Applications:
ELISA
Species:
Coronavirus SARS-CoV
Applications:
ELISA
Species:
Coronavirus SARS-CoV
Applications:
ELISA
Species:
Coronavirus SARS-CoV
Applications:
ELISA
Species:
Coronavirus SARS-CoV
Applications:
Western blot
Species:
Coronavirus SARS-CoV
Applications:
Western blot, ELISA
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 11/24/2024